Date: Sunday, October 21, 2018
Session Title: Fibromyalgia and Other Clinical Pain Syndromes Poster
Session Type: ACR Poster Session A
Session Time: 9:00AM-11:00AM
Background/Purpose: We asked patients with fibromyalgia to rank the effectiveness of medications they have tried.
Methods: In a rheumatology office practice, 95 patients (mean age 50.5) who met the 2010 ACR criteria for fibromyalgia (88 females and seven males) completed an in-office questionnaire regarding the effectiveness of various medications used to treat fibromyalgia. The medications included pregabalin, gabapentin, duloxetine, various muscle relaxants, sleep aids, stimulants, pain medications, and nonsteroidal anti-inflammatory medicines. Patients rated the medications on a 1 to 4 scale from not helpful to very helpful.
Results: See tables
Conclusion: There were much higher effectiveness results for pain medications, sleeping aids, stimulants, muscle relaxants, and anti-inflammatory drugs than for pregabalin and duloxetine, which are both FDA-approved medications.
Fibromyalgia patients in this office survey concluded that the FDA approved medications for fibromyalgia were ineffective compared with other medications tried for this disorder.
To cite this abstract in AMA style:Katz RS. The Effectiveness of Medications for Fibromyalgia Based on Patient Experiences [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10). https://acrabstracts.org/abstract/the-effectiveness-of-medications-for-fibromyalgia-based-on-patient-experiences-3/. Accessed May 19, 2022.
« Back to 2018 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effectiveness-of-medications-for-fibromyalgia-based-on-patient-experiences-3/